Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Gynecologic 1Gastrointestinal 1Breast 1

Conditions

Endometrial Neoplasms 2Carcinosarcoma 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Salivary Gland Neoplasms 1Osteosarcoma 1Neoplasm Metastasis 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Endometrioid 1Breast Neoplasms 1

Interventions

Docetaxel 3trastuzumab deruxtecan 2entrectinib 2Magnetic Resonance Spectroscopy 2Fluorodeoxyglucose F18 2Erlotinib Hydrochloride 2Biopsy 2pembrolizumab 1larotrectinib 1entinostat 1ceralasertib 1alectinib 1Thalidomide 1Taxes 1Specimen Handling 1Ritonavir 1Radiotherapy 1Quality of Life 1Polymerase Chain Reaction 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Irinotecan 1Indinavir 1Immunotherapy 1Immunohistochemistry 1Gene Expression Profiling 1Gemcitabine 1Fluorescent Antibody Technique 1Flow Cytometry 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Salivary Gland Neoplasms × ceralasertib × Sarcoma × Clear all
NCT04704661 2026-05-13

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

National Cancer Institute (NCI)

Phase 1 Active not recruiting
51 enrolled
BreastGastrointestinalGynecologicHead & NeckSarcoma

Breast Neoplasms, Carcinosarcoma, Colonic Neoplasms, Neoplasm Metastasis, Salivary Gland Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡